The newly-approved drug was shown to slow the progression of symptoms of ALS in a Phase 2 trial.
Read More
Recent Posts
- Japan’s chief trade negotiator will visit Washington to deal with Trump tariffs prime minister calls ‘a national crisis’
- ASML maintains 2025 forecast but CEO warns of increased macroeconomic uncertainty driven by U.S. tariffs
- Student pilots are suing United Airlines for fraud after spending tens of thousands of dollars on a flight school riddled with staffing shortages and expulsions: ‘It was students teaching students’
- Tariffs are coming for America’s favorite beer—but Modelo maker says it’s Trump’s immigration crackdown that’s hurting sales
- How CEOs should deal with Trump—even if it means ‘vaporware’ announcements
Archives
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
Recent Comments